Early V-safe Free-Text Entries Show Remarkable Consistency in the Frequency of Mentions of Adverse Events
ICAN Challenges FDA’s Move to Weaken its Already Paltry Clinical Trial Requirements for Vaccine Approval
ICAN Uncovers a Potential Next-Level Threat: “Inhalable” Self-Spreading Vaccines that Spread Like a Virus
